Connect today @

info@skinvisible.com

NEWS RELEASES
  • Home
  • TECHNOLOGY
  • PATENTS
  • PIPELINE
    • Dermatology
    • Rare Skin Diseases
    • Obesity
    • Small Molecules
    • Life Cycle Management
  • LICENSEES
  • INVESTORS
    • Company Info
    • Management Team
    • News
  • CONTACT
Login
  • Home
  • TECHNOLOGY
  • Patents
  • PIPELINE
    • Dermatology
    • Rare Skin Diseases
    • Obesity
    • Small Molecules
    • Life Cycle Management
  • Licensees
  • INVESTORS
    • Company Info
    • Management Team
  • Press

Copyright © 2025 Skinvisible Pharmaceuticals, Inc. All Rights Reserved.

  • >
  • Portfolios
  • >
  • USA
portfolio8-min
Pathology, VACCINES
Photoswitchable Inhibitors
portfolio9-min
Incubator
Surface Cleaning
thumbgallery3-min
Oncology
Translational Research
portfolio6-min
VACCINES
Polymer Science
portfolio5-min
Oncology
Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency
portfolio4-min
Pathology
A Systematic Exploration of the Human Interactome
portfolio3-min
Oncology
Elucidating Compound Mechanism of Action by Network Perturbation Analysis
portfolio2-min
Oncology
Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human
Facebook-f Instagram Linkedin-in
Company Info
PIPELINE
  • Dermatology
  • Rare Skin Disorders
  • Obesity Treatment
  • Small Molecule Therapies
  • Life Cycle Management
Investors
  • Company Info
  • Management Team
  • Press & News
About us
  • Home page
  • Contact Us

Newsletter

Keep up with our news releases.

© 2026 Skinvisible Pharmaceuticals, Inc. All Rights Reserved.

Login

Forgot password?